Table 2. Antibiotic prescribing rates for URTI in the Asia-Pacific countriesa .
Country | Author, year | Setting | Patients or prescriptions (n) | Antibiotic prescribing rate (%) | Other remarks |
Australia | Pan, 200636 | General practice clinics | 2088 | 40% (adult) 24% (children) | Bettering evaluation and care of health (BEACH) data for the years 2002-2003 |
China | Jiang, 201237 | 30 township health centres | 3,059 | 85 | 25% of prescriptions contained two or more types of antibiotics |
Hong Kong | Kung, 201438 | 74 public clinics | 895978 | 5 | Computerised record for the year 2010 |
Japan | Higashi, 200939 | Outpatient clinics | 2577 | 60 | Outpatient visit claims in a health insurance plan. Types of antibiotics: Third-generation cephalosporin (46%), macrolide (27%) and quinolone (16%), penicillin (4%) |
Korea | Park, 200540 | Outpatient clinics | 16736 | 81 | Viral illness (including URTI). Ambulatory visit claims in a national health insurance programme in 2000 |
Indonesia | Marjadi, 200941 | Outpatient clinics | 6804 | 70 (public), 47 (private) | Extracted from PhD thesis |
Malaysia | Fozi, 201342 | Outpatient clinics | 22,328 | 34 | Pre-intervention data in 2010. Antibiotic choices: macrolide 61%, penicillin 36% (penicillin V 0.4%) |
New Zealand | Kljakovic, 200543 | 246 GP clinics | 335 | 61 | 10506 records from 246 GPs. Sore throat as a presentation |
Taiwan | Hou, 201444 | Outpatient clinics | 6915140 | 6 | Ambulatory visit claims in a national health insurance programme |
Thailand | Issarachaikul, 201345 | Outpatient clinics | 339 | 81 | Antibiotic choices: Penicillin, 71%, macrolide 21% |
a The largest and latest study for each country has been preferentially cited.